Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.30 CAD
Change Today -0.025 / -7.81%
Volume 102.4K
COT On Other Exchanges
As of 2:01 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

critical outcome technologie (COT) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/10/15 - C$0.38
52 Week Low
10/1/14 - C$0.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

critical outcome technologie (COT) Related Businessweek News

No Related Businessweek News Found

critical outcome technologie (COT) Details

Critical Outcome Technologies Inc., a clinical stage biopharmaceutical company, engages in the development of various therapies using artificial intelligence platform in Canada. Its artificial intelligence platform, CHEMSAS, utilizes various computer models to identify compounds from disease specific drug discovery through chemical optimization and preclinical testing. The company develops various drug candidates for the treatment of various human cancers, including small cell lung, non-small cell lung, colon, brain, ovarian, endometrial, triple negative breast, head and neck, and pancreatic, as well as acute myelogenous leukemia, HIV, multiple sclerosis, and Alzheimer’s disease. Critical Outcome Technologies Inc. was founded in 1999 and is based in London, Canada.

Founded in 1999

critical outcome technologie (COT) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: C$170.0K
Chief Financial Officer
Total Annual Compensation: C$130.0K
Compensation as of Fiscal Year 2014.

critical outcome technologie (COT) Key Developments

Critical Outcome Technologies Inc. Announces Earnings Results for the Fourth Quarter and Year Ended April 30, 2015

Critical Outcome Technologies Inc. announced earnings results for the fourth quarter and year ended April 30, 2015. For the fourth quarter, the company reported net loss of $946,683, or $0.01 per share, compared to a net loss of $1,226,521, or $0.01 per share, for the fourth quarter of the previous year. The $279,838 decrease in net loss was attributable to a $173,766 decrease in research and development expenditures and a $163,339 decrease in general and administrative expenditures, partially offset by higher sales and marketing expenses, a decrease in investment tax credits, and a $148,368 increase in financing expenses. For the year, the company had a loss of $3,813,186, or $0.04 per share, compared to a net loss of $2,996,179, or $0.03 per share, for the previous year. The increased loss of $817,007 was attributable to a $321,092 increase in R&D expenses, a $383,869 increase in G&A expenses, and a $180,712 increase in sales and marketing expenses.

Critical Outcome Technologies Inc. to Report Q4, 2015 Results on Aug 24, 2015

Critical Outcome Technologies Inc. announced that they will report Q4, 2015 results on Aug 24, 2015

Critical Outcome Technologies Inc. Presents at BIO International Convention 2015, Jun-16-2015 10:15 AM

Critical Outcome Technologies Inc. Presents at BIO International Convention 2015, Jun-16-2015 10:15 AM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COT:CN C$0.30 CAD -0.025

COT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for COT.
View Industry Companies

Industry Analysis


Industry Average

Valuation COT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 10.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CRITICAL OUTCOME TECHNOLOGIE, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at